<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100932">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02050659</url>
  </required_header>
  <id_info>
    <org_study_id>OMEGA</org_study_id>
    <nct_id>NCT02050659</nct_id>
  </id_info>
  <brief_title>What is the Tumour Load in the Greater Omentum Distal From the Gastro-epiploic Vessels in Patients With Potentially Curative Gastric Cancer?</brief_title>
  <acronym>OMEGA</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <authority>Netherlands: Medical Ethics Review Committee (METC)</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients with gastric cancer, traditionally a complete omentectomy is performed as part
      of a radical gastrectomy with a modified D2 lymph node dissection. The omentectomy increases
      operation time significantly, especially in laparoscopic procedures. Patients remain more
      vulnerable for peritoneal infections and intestinal adhesions following omentectomy.
      Furthermore one can debate whether a complete omentectomy is indicated from an oncologic
      viewpoint. In the present study we prospectively evaluated the presence of tumor load in the
      greater omentum of patients with potentially curative gastric cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>tumorload in the greater omentum</measure>
    <time_frame>at the time of pathologic investigation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">95</enrollment>
  <condition>Omentum</condition>
  <condition>Stomach Neoplasms</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with a castric carcinoma who received an in potentially curative gastric
        resection
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  an in potentially curative gastric cancer

          -  age &gt; 18 year

        Exclusion Criteria:

          -  palliative resection

          -  age &lt; 18 year
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Academic Medical Centre</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SS Gisbertz, MD PhD</last_name>
      <phone>+31205669111</phone>
      <email>s.s.gisbertz@amc.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 29, 2014</lastchanged_date>
  <firstreceived_date>January 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>S.S. Gisbertz</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
